Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company specializing in oncology, cardiovascular, and immunology products, committed to scientific innovation and health equity.
Global Operations
Bristol Myers Squibb (BMS) operates in multiple countries, including the United States, Canada, Australia, China, Japan, and a number of European nations. This expansive global presence allows BMS to deliver its biopharmaceutical products and services to a diverse international market. The company's wide-reaching footprint enables it to engage with various healthcare systems, meet the needs of patients around the world, and contribute to global health advancements.
Biopharmaceutical Products
Bristol Myers Squibb offers a range of biopharmaceutical products primarily focused on oncology, cardiovascular, and immunology. These products are the result of the company's commitment to scientific excellence and innovation in biopharmaceutical research. BMS strives to develop therapies that address critical medical needs and improve patient outcomes in these key therapeutic areas.
Study Connect Platform
Bristol Myers Squibb provides access to clinical trial information through its platform, Study Connect. This resource is designed to help patients, caregivers, and healthcare professionals find and participate in clinical trials. Study Connect is part of BMS's broader commitment to transparency in clinical research and patient engagement, offering detailed information about ongoing and upcoming trials.
Dedicated Medical Information Portal
To support healthcare providers, Bristol Myers Squibb offers a dedicated medical information portal. This portal provides comprehensive medical information and resources, facilitating informed decision-making in clinical settings. It includes data on BMS's products, safety information, and guidance on their use, helping healthcare professionals deliver better care to their patients.
Patient Access Programs
Bristol Myers Squibb is committed to supporting patient access to medications through various programs and initiatives. These efforts are designed to ensure that patients, especially those in underserved communities, can obtain the medications they need. BMS also advocates for policies that promote health equity, aiming to eliminate barriers to essential healthcare services and improve access to care.